Complications associated with antibiotic administration: neurological adverse events and interference with antiepileptic drugs

被引:24
|
作者
Esposito, Susanna [1 ]
Canevini, Maria Paola [2 ]
Principi, Nicola [3 ]
机构
[1] Univ Perugia, Pediat Clin, Piazza Lucio Severi 1, I-06132 Perugia, Italy
[2] Univ Milan, Dept Hlth Sci, San Paolo Hosp, Child Neurol Unit,Epilepsy Ctr, Milan, Italy
[3] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy
关键词
Antibiotics; Adverse events; Antiepileptic drugs; Antituberculosis drugs; Neurotoxicity; Drug interactions; BETA-LACTAM ANTIBIOTICS; ISONIAZID-INDUCED PSYCHOSIS; NERVOUS-SYSTEM TOXICITY; INDUCED NEUROTOXICITY; PERIPHERAL NEUROPATHY; OPTIC NEUROPATHY; CEFEPIME NEUROTOXICITY; NEUROMUSCULAR BLOCKADE; INDUCED ENCEPHALOPATHY; CLINICAL-IMPLICATIONS;
D O I
10.1016/j.ijantimicag.2017.01.027
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antibiotic use is associated with toxic effects involving the peripheral and central nervous systems and it may interfere with antiepileptic drugs, causing significant variations in their serum levels and activity. Prompt identification of neurological complications during antibiotic therapy is important in order to make appropriate modifications to medication. Characteristics of the drug and the patient, including age and underlying diseases, may favour these complications. The main aim of this study was to review the neurological adverse events that may follow antibiotic administration, the mechanisms that cause them, and the possibility of prevention and treatment. Moreover, the interference of antibiotics with serum levels and the activity of antiepileptic drugs are discussed. The results demonstrate that antibiotic-associated adverse events involving the nervous system are relatively uncommon and are only rarely severe and irreversible, although neurotoxicity has been reported for several antibiotics. Moreover, for patients receiving antiepileptic drugs, monitoring of drug serum levels to avoid the risk of toxicity or inadequate therapy is mandatory during antibiotic treatment. Areas for future research include the effects of combined antibiotic therapies as well as multiple antiepileptic drugs in study populations with an adequate sample size, including neonates and infants, patients with pharmacoresistant epilepsy and elderly patients. (C) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: A comparison of common parenteral drugs
    Roback, MG
    Wathen, JE
    Bajaj, L
    Bothner, JP
    ACADEMIC EMERGENCY MEDICINE, 2005, 12 (06) : 508 - 513
  • [42] A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database
    Koseki, Takenao
    Horie, Mikako
    Kumazawa, Satomi
    Nakabayashi, Tetsuo
    Yamada, Shigeki
    FRONTIERS IN PSYCHIATRY, 2023, 13
  • [43] Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022
    Rathi, Vinay K. K.
    Sawicki, Nicholas W. W.
    Schlosser, Rodney J. J.
    Soler, Zachary M. M.
    Scangas, George A. A.
    Workman, Alan D. D.
    Gray, Stacey T. T.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (01) : 123 - 126
  • [44] Can Improving Knowledge of Antibiotic-Associated Adverse Drug Events Reduce Parent and Patient Demand for Antibiotics?
    Roberts, Rebecca M.
    Albert, Alison P.
    Johnson, Darcia D.
    Hicks, Lauri A.
    HEALTH SERVICES RESEARCH AND MANAGERIAL EPIDEMIOLOGY, 2015, 2
  • [45] A pharmacovigilance study of adverse events associated with polymyxins based on the US Food and Drug Administration Adverse Event Reporting System (FAERS) database
    Wu, Tingxi
    Shi, Yanfeng
    Xu, Chang
    Zhu, Bin
    Li, Dandan
    Li, Zhe
    Zhao, Zhigang
    Zhang, Yang
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (01) : 69 - 77
  • [46] Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook
    Moehn, Nora
    Beutel, Gernot
    Gutzmer, Ralf
    Ivanyi, Philipp
    Satzger, Imke
    Skripuletz, Thomas
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [47] Ultrasonic Device Complications in Endodontics: An Analysis of Adverse Events From the Food and Drug Administration Manufacturer and User Facility Device Experience
    Rhodes, S. Craig
    JOURNAL OF PATIENT SAFETY, 2022, 18 (04) : 269 - 275
  • [48] Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
    Jiao, Xue-Feng
    Song, Kunpeng
    Jiao, Xueyan
    Li, Hailong
    Zeng, Linan
    Zou, Kun
    Zhang, Wei
    Wang, Huiqing
    Zhang, Lingli
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [49] Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
    Makunts, Tigran
    Alpatty, Sama
    Lee, Kelly C.
    Atayee, Rabia S.
    Abagyan, Ruben
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [50] Adverse events associated with potential drugs for COVID-19: a case study from real-world data
    Jing, Ying
    Diao, Lixia
    Han, Leng
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 1232 - 1238